Smart insulin pump may shield kidneys in diabetes patients

NCT ID NCT06925217

Recruiting now Disease control Sponsor: Heba Al-Alwan Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a fully automated insulin delivery system (CamAPS HX) can improve kidney oxygen levels in people with type 2 diabetes and chronic kidney disease. About 76 adults will use either the automated system or standard insulin therapy with a glucose monitor for 26 weeks. The main goal is to see if the automated system helps protect kidney tissue.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CamAPS HX fully closed-loop insulin delivery system (device)
What this could lead to: If successful, this could show that automated insulin delivery helps protect kidney function in people with type 2 diabetes and kidney disease.
What could go wrong: This is a small, early-stage study (76 people) focused on a kidney imaging marker, not hard outcomes like kidney failure. The device may not improve kidney health or could cause hypoglycemia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE, STAGE 3 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE, STAGE 3 TYPE 2 DIABETES

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHUV
RECRUITING

Lausanne, Switzerland

Contact Phone: •••-•••-•••• Email: •••••@•••••
Centre Hospitalier Universitaire Vaudois
NOT_YET_RECRUITING

Lausanne, Canton of Vaud, 1011, Switzerland

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.